Bavarian Nordic’s mpox vaccine, Jynneos (MVA-BN), is set to be trialled in pregnant and breastfeeding women and infants. The Phase III trial (PregInPoxVac) will enrol around 350 pregnant women and 250 ...
Today's health news includes what RFK Jr. can do on vaccines, escaped monkeys, and who know in the Make America Healthy Again ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
In September, after facing criticism on moving too slowly on vaccines, the World Health Organization cleared Bavarian ...
One of the World Health Organization’s most important jobs is managing viral outbreaks. The rapid spread of mpox, a disease related to smallpox, is a reminder of its shortcomings. The WHO has ...
As the U.K. works to pump fresh cash into the local biopharma scene, London’s Accord Healthcare is capitalizing on the government’s renewed willingness to chip in. | Flush with a 50 million pound ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Africa Centers for Disease Control and Prevention has estimated Congo needs at least 3 million mpox vaccines to stop the ...
Medpage Today on MSN3d
Mpox Cases in Congo May Be Stabilizing"What we need is a public health approach where we immunize populations at scale." Drugmaker Bavarian Nordic, which makes the ...
Two additional cases of a new strain of mpox have been detected in Britain, national health officials said Monday, less than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback